Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-98.80	18.72	-1560.48
Graham Fair Price	41.42	26.95	19.06
PEG	-72.10	0.07	-0.24
Price/Book	-12.08	0.40	0.46
Price/Cash Flow	-74.52	14.05	55.16
Prices/Earnings	-56.04	6.40	14.55
Price/Sales	-52.22	7.46	15.61
Price/FCF	-74.52	14.05	55.16
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-61.73	0.38	1.00
Operating Margin	-16.97	0.28	0.34
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	0.01	52.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.48	0.22	121.77
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.56	0.53	-5.09
EPS QOQ	-0.62	0.97	57.57
FCF QOQ	1.58	2.45	55.21
Revenue QOQ	-0.51	0.84	66.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	438.94	100.00
Days Sales Outstanding (DSO)	0.00	459.14	100.00
Inventory Turnover	0.00	0.21	100.00
Debt/Capitalization	0.04	0.02	-47.63
Quick Ratio	2.96	8.25	178.59
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	45.38	45.38	< 0.005
Cash	1.27	21.82	1611.64
Capex	0.00	-0.01	-100.00
Free Cash Flow	0.38	1.29	245.08
Revenue	1.33	2.44	84.01
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.96	7.90	166.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-29.11	-6.37	78.11
Naive Interpretation	Member

06 - Financial Health · Bad

Rating